Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria
Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of pyronaridine-artesunate and
artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in
Kenyan children.